Latest Distribution Partnerships News

OMG Group has reported a record-breaking November with $720,000 in sales, driving a 68% revenue increase year-to-date. Strong ecommerce and retail growth set the stage for a promising summer season.

Algorae Pharmaceuticals has secured a key distribution agreement with global giant Dr. Reddy’s Laboratories to supply the chemotherapy drug Capecitabine in Australia, marking a significant step in its oncology commercialisation strategy.

Osteopore Limited has partnered with DKSH Malaysia in a five-year agreement to distribute its innovative dental products, aiming to capture significant growth in Malaysia’s guided bone regeneration sector.

ECS Botanics has achieved a milestone with direct-to-consumer sales exceeding 60% of total revenue, driven by the launch of innovative sugar-free THC gummies and a strategic distribution partnership.

HITIQ Limited has launched its PROTEQT™ concussion management system in North America, securing exclusive Canadian distribution rights and initiating a dual-channel market strategy targeting hockey’s vast ecosystem.

Merino & Co. has secured a significant distribution agreement with a Shanghai-based omni-channel partner, committing to annual sales of approximately A$1.5 million and expanding its footprint in China’s luxury fashion market.

Shriro Holdings reported a 13.6% revenue decline in FY25 amid a strategic shift in its BBQ segment but delivered a 5.5% rise in EBITDA. The company plans a $20 million share buy-back in FY26, signaling confidence in its operational turnaround.

CurveBeam AI reports a 33% rise in device purchase orders and secures a $6.5 million placement alongside a landmark China distribution partnership. The company advances FDA regulatory milestones and establishes a vendor financing facility to boost sales.

Murray Cod Australia Ltd reports a robust start to FY26 with a 45% increase in sales and a $17 million capital raise, driven by expanded production and market access including new Halal certification.

AML3D Limited reported steady quarterly receipts alongside a landmark US Navy Letter of Intent and significant orders, underpinning a major growth phase in the US and Europe.

BrainChip Holdings has moved its AKD1500 neuromorphic AI chip into volume production, supported by key supply agreements and expanded distribution channels, while maintaining a stable cash position.

INOVIQ Limited has launched an A$11.5 million capital raise to fast-track clinical validation and commercialization of its ovarian cancer screening test and advance its CAR-exosome therapeutic program targeting solid tumors.